Effect of the Glycine Antagonist Gavestinel on Cerebral Infarcts in Acute Stroke Patients, a Randomized Placebo-Controlled Trial: The GAIN MRI Substudy

Publisher： Karger

E-ISSN： 1421-9786|21|1-2|106-111

ISSN： 1015-9770

Source： Cerebrovascular Diseases, Vol.21, Iss.1-2, 2006-01, pp. : 106-111

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Glycine Antagonist (GV150526) in Acute Stroke: A Multicentre, Double-Blind Placebo-Controlled Phase II Trial

By  

Cerebrovascular Diseases, Vol. 11, Iss. 1, 2001-01 ,pp. : 20-29

Karger

Access to resources Recommend Favorite

Effect of Cilostazol on Cerebral Vasospasm and Outcome in Patients with Aneurysmal Subarachnoid Hemorrhage: A Randomized, Double-Blind, Placebo-Controlled Trial

By  

Cerebrovascular Diseases, Vol. 42, Iss. 1-2, 2016-04 ,pp. : 97-105

Karger

Access to resources Recommend Favorite

The AMPA Antagonist ZK 200775 in Patients with Acute Ischaemic Stroke: A Double-Blind, Multicentre, Placebo-Controlled Safety and Tolerability Study

By  

Cerebrovascular Diseases, Vol. 20, Iss. 5, 2005-11 ,pp. : 304-309

Karger

Access to resources Recommend Favorite

Effect of Methylphenidate and/or Levodopa Combined with Physiotherapy on Mood and Cognition after Stroke: A Randomized, Double-Blind, Placebo-Controlled Trial

By  

European Neurology, Vol. 66, Iss. 1, 2011-06 ,pp. : 7-13

Karger

Access to resources Recommend Favorite

Hydroxyethyl Starch for Hypervolemic Hemodilution in Patients with Acute Ischemic Stroke: A Randomized, Placebo-Controlled Phase II Safety Study

By  

Cerebrovascular Diseases, Vol. 14, Iss. 1, 2002-06 ,pp. : 33-41

Karger

Access to resources Recommend Favorite